Richard W. Franck - Publications

Affiliations: 
Chemistry City University of New York, New York, NY, United States 
Area:
Organic Chemistry

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Altiti AS, Ma X, Zhang L, Ban Y, Franck RW, Mootoo DR. Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residues. Carbohydrate Research. 443: 73-77. PMID 28365448 DOI: 10.1016/j.carres.2017.03.005  1
2015 Birkholz A, Nem?ovi? M, Yu ED, Girardi E, Wang J, Khurana A, Pauwels N, Farber E, Chitale S, Franck RW, Tsuji M, Howell A, Van Calenbergh S, Kronenberg M, Zajonc DM. Lipid and Carbohydrate Modifications of α-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation. The Journal of Biological Chemistry. 290: 17206-17. PMID 26018083 DOI: 10.1074/jbc.M115.654814  1
2011 Patel O, Cameron G, Pellicci DG, Liu Z, Byun HS, Beddoe T, McCluskey J, Franck RW, Castaño AR, Harrak Y, Llebaria A, Bittman R, Porcelli SA, Godfrey DI, Rossjohn J. NKT TCR recognition of CD1d-α-C-galactosylceramide. Journal of Immunology (Baltimore, Md. : 1950). 187: 4705-13. PMID 21964029 DOI: 10.4049/jimmunol.1100794  1
2011 Aspeslagh S, Li Y, Yu ED, Pauwels N, Trappeniers M, Girardi E, Decruy T, Van Beneden K, Venken K, Drennan M, Leybaert L, Wang J, Franck RW, Van Calenbergh S, Zajonc DM, et al. Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis. The Embo Journal. 30: 2294-305. PMID 21552205 DOI: 10.1038/emboj.2011.145  1
2011 Chang YJ, Kim HY, Albacker LA, Lee HH, Baumgarth N, Akira S, Savage PB, Endo S, Yamamura T, Maaskant J, Kitano N, Singh A, Bhatt A, Besra GS, van den Elzen P, ... ... Franck RW, et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. The Journal of Clinical Investigation. 121: 57-69. PMID 21157038 DOI: 10.1172/JCI44845  1
2010 Schmieg J, Yang G, Franck RW, Tsuji M. A multifactorial mechanism in the superior antimalarial activity of alpha-C-GalCer. Journal of Biomedicine & Biotechnology. 2010: 283612. PMID 20069056 DOI: 10.1155/2010/283612  1
2010 Sullivan BA, Nagarajan NA, Wingender G, Wang J, Scott I, Tsuji M, Franck RW, Porcelli SA, Zajonc DM, Kronenberg M. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 141-53. PMID 19949076 DOI: 10.4049/jimmunol.0902880  1
2009 Li X, Shiratsuchi T, Chen G, Dellabona P, Casorati G, Franck RW, Tsuji M. Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 4415-21. PMID 19734232 DOI: 10.4049/jimmunol.0901021  1
2009 Li X, Chen G, Garcia-Navarro R, Franck RW, Tsuji M. Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells. Immunology. 127: 216-225. PMID 19489127  1
2009 Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, Tsuji M, Palese P. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine. 27: 3766-74. PMID 19464560 DOI: 10.1016/j.vaccine.2009.03.090  1
2008 Parhi AK, Mootoo DR, Franck RW. Synthesis of the Mixed Acetal Segment of S-Glyceroplasmalopsychosine. Tetrahedron. 64: 9821-9827. PMID 19829689 DOI: 10.1016/j.tet.2008.08.023  1
2008 Pu J, Franck RW. C-Galactosylceramide Diastereomers via Sharpless Asymmetric Epoxidation Chemistry. Tetrahedron. 64: 8618-8629. PMID 19746154 DOI: 10.1016/j.tet.2008.06.007  1
2008 Grajewski RS, Hansen AM, Agarwal RK, Kronenberg M, Sidobre S, Su SB, Silver PB, Tsuji M, Franck RW, Lawton AP, Chan CC, Caspi RR. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses. Journal of Immunology (Baltimore, Md. : 1950). 181: 4791-7. PMID 18802082  1
2007 Coppieters K, Van Beneden K, Jacques P, Dewint P, Vervloet A, Vander Cruyssen B, Van Calenbergh S, Chen G, Franck RW, Verbruggen G, Deforce D, Matthys P, Tsuji M, Rottiers P, Elewaut D. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner. Journal of Immunology (Baltimore, Md. : 1950). 179: 2300-9. PMID 17675491  1
2007 Teng MW, Westwood JA, Darcy PK, Sharkey J, Tsuji M, Franck RW, Porcelli SA, Besra GS, Takeda K, Yagita H, Kershaw MH, Smyth MJ. Combined natural killer T-cell based immunotherapy eradicates established tumors in mice. Cancer Research. 67: 7495-504. PMID 17671220 DOI: 10.1158/0008-5472.CAN-07-0941  1
2006 Franck RW, Tsuji M. Alpha-c-galactosylceramides: synthesis and immunology. Accounts of Chemical Research. 39: 692-701. PMID 17042469 DOI: 10.1021/ar050006z  1
2006 Fujii S, Shimizu K, Hemmi H, Fukui M, Bonito AJ, Chen G, Franck RW, Tsuji M, Steinman RM. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proceedings of the National Academy of Sciences of the United States of America. 103: 11252-7. PMID 16844772 DOI: 10.1073/pnas.0604812103  1
2006 Chen G, Chien M, Tsuji M, Franck RW. E and Z alpha-C-galactosylceramides by Julia-Lythgoe-Kocienski chemistry: a test of the receptor-binding model for glycolipid immunostimulants. Chembiochem : a European Journal of Chemical Biology. 7: 1017-22. PMID 16795118 DOI: 10.1002/cbic.200500386  1
2005 Schmieg J, Yang G, Franck RW, Van Rooijen N, Tsuji M. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proceedings of the National Academy of Sciences of the United States of America. 102: 1127-32. PMID 15644449 DOI: 10.1073/pnas.0408288102  1
2004 Chen G, Schmieg J, Tsuji M, Franck RW. Efficient synthesis of alpha-C-galactosyl ceramide immunostimulants: use of ethylene-promoted olefin cross-metathesis. Organic Letters. 6: 4077-80. PMID 15496103 DOI: 10.1021/ol0482137  1
2004 Parhi AK, Franck RW. A Weinreb nitrile oxide and nitrone for cycloaddition. Organic Letters. 6: 3063-5. PMID 15330588 DOI: 10.1021/ol0489752  1
2004 Yang G, Schmieg J, Tsuji M, Franck RW. The C-glycoside analogue of the immunostimulant alpha-galactosylceramide (KRN7000): synthesis and striking enhancement of activity. Angewandte Chemie (International Ed. in English). 43: 3818-22. PMID 15258945 DOI: 10.1002/anie.200454215  1
2003 Schmieg J, Yang G, Franck RW, Tsuji M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide. The Journal of Experimental Medicine. 198: 1631-41. PMID 14657217 DOI: 10.1084/jem.20031192  1
Show low-probability matches.